“Efficacy of Empagliflozin As Add-on Therapy in Patients With Uncontrolled Type 2 Diabetes Mellitus”. 2023. TAJ: Journal of Teachers Association 36 (1): 89-95. https://doi.org/10.3329/taj.v36i1.68304.